In a new job - May 12, 2015
Oasmia Names Mikael Asp CEO
Mikael Asp has been appointed the new CEO of Oasmia pharmaceutical company. He succeeds Julian Aleksov, who has been nominated as the company’s new chairman of the board of directors. Current Board President Joel Lemon announced that he wishes to resign. Asp currently is head of quality assurance at the company and has many years […]